Alivus Life Sciences Limited has intimated the stock exchanges about its Fifteenth (15th) Annual General Meeting (AGM) and related dividend matters.
The 15th AGM of the company will be held on Tuesday, September 8, 2026, at 03:00 pm (IST) through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting is being conducted in accordance with relevant circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India (SEBI).
The Board of Directors at its meeting held on May 14, 2026, had recommended a final dividend of ₹5.00 per equity share of ₹2 each for the financial year ended March 31, 2026. This dividend recommendation is subject to approval by shareholders at the AGM.
If the dividend is approved at the AGM, payment will be made on or after Friday, September 11, 2026, subject to deduction of tax at source. The payment will be made:
- To all Beneficial Owners holding shares in dematerialized form, based on data provided by National Securities Depository Limited and Central Depository Services (India) Limited as of close of business hours on September 1, 2026
- To all Members holding shares in physical form, after giving effect to valid transmission or transposition requests lodged with the company as of close of business hours on September 1, 2026
The disclosure was signed by Rudalf Joseph Corriea, Company Secretary & Compliance Officer, on August 6, 2026, at 14:53:49 IST. The company's Corporate Office is located at Technopolis Knowledge Park, A wing, Office No. 401 to 407, 4th Floor, Mahakali Caves Road, Andheri (E), Mumbai – 400093, and Registered Office at Plot No 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213, India. The company's CIN is L74900PN2011PLC139963.